A Phase 1 Dose Escalation and Expansion Study of AK117

Clinical trial NCT04728334 · COMPLETED

Trial details

NCT number: NCT04728334
Sponsor: Akeso
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Malignant

Start date: 2021-03-23
Primary completion: 2022-01-25
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.